Pomegra
Guidewire will pay $1.7B in cash for UK insurance AI startup Hyperexponential, plus up to $400M in earnouts, in a bid to own insurer front-office pricing.
Key Takeaways
- Guidewire pays $1.7B in cash, plus up to $400M tied to recurring revenue targets, announced October 27, 2026.
- A $1B term loan from Bank of America and Citibank funds part of the deal. Closing is expected by January 31, 2027.
- Hyperexponential raised about $91M in total. The base price is roughly 19x that capital.
Lead
Guidewire announced on October 27, 2026 that it will acquire Hyperexponential, a London-based maker of AI-native pricing and underwriting software for commercial insurers, for $1.7B in cash. Up to $400M more is payable if the business hits recurring revenue targets, which puts the maximum value near $2.1B. The purchase is strategic rather than an acquihire. Guidewire is buying a product with about 600 insurer customers in 40 countries, and it already sells to many of the same carriers.
What Are the Deal Terms?
The deal combines a $1.7B cash payment with a $400M contingent earnout tied to recurring revenue. Guidewire is financing part of it with a $1B senior secured term loan A, committed by Bank of America and Citibank and maturing in December 2029. The rest comes from cash on hand.
Closing is expected in Guidewire's fiscal second quarter of 2027, which ends January 31, 2027. Guidewire has said the acquisition should add at least 650 basis points to its fiscal 2027 annual recurring revenue growth. That compares with fiscal 2026 ARR of $1.237B, up 19% in constant currency. Updated guidance is due on the company's December earnings call. Centerview Partners advised Guidewire, and J.P. Morgan advised Hyperexponential.
Why Did Guidewire Pay So Much?
Guidewire paid for a position in underwriting, the part of an insurer's workflow its core systems do not touch. Its software has run policy administration and claims for more than 570 insurers in 44 countries. Hyperexponential sits upstream, where risks are selected and priced. That moves Guidewire from the back office toward the front office.
Timing matters too. Guidewire launched embedded AI tools in April and an agentic framework in August. Hyperexponential released its Hyperoperator agent in July, which handles assessment, pricing and quoting within carrier controls. Buying a working agent product is faster than building one.
The price also stands out against Guidewire's own history. Its 2017 purchase of Cyence cost $275M, so this deal is roughly six times that. Hyperexponential has not disclosed revenue, headcount or its last private valuation, which makes the multiple hard to judge. The 650 basis point ARR contribution is the only public indicator of its scale.
What Does the Funding History Imply?
The funding history shows a company that raised little and sold for a lot. Hyperexponential, founded in 2017, raised an $18M Series A in 2021 led by Highland Europe. It followed with a $73M Series B in January 2024 led by Battery Ventures, with participation from Andreessen Horowitz. Total disclosed funding is about $91M, so the base price is around 19x capital raised.
For those investors, the exit came roughly 22 months after the Series B. The company never needed a larger growth round. That points to capital efficiency, though the undisclosed Series B valuation leaves the actual return unknown.
One detail complicates the picture. Marcus Ryu, Guidewire's co-founder and former CEO, led Battery's participation in the Series B and joined Hyperexponential's board. Guidewire is therefore buying a company its own co-founder backed. The disclosures do not describe any special process, and the 8-K filing leaves governance questions to the buyer's board.
Who Founded Hyperexponential?
Amrit Santhirasenan, CEO, and Michael Johnson founded Hyperexponential. The company is already a Guidewire PartnerConnect Technology Alliance Partner, so the integration builds on an existing relationship. Its platform supports underwriting decisions on more than $75B of annual commercial premium. Its customer base is strongest among UK and London market carriers.
Guidewire CEO Mike Rosenbaum said the company is "delighted to welcome Amrit Santhirasenan and the team." Santhirasenan said the company was founded on the conviction that underwriting judgment is the highest-leverage work insurers do.
What Comes Next for Insurance Software?
Rivals now face a harder choice: build, buy or partner for underwriting AI. Pricing and underwriting vendors that stayed independent are now more visible acquisition targets, and the Hyperexponential price sets a reference point for those talks.
Integration is the main risk. Hyperexponential's carriers chose it partly because it was independent of any core-system vendor. Some may resist deeper ties to Guidewire, and the earnout's revenue conditions give Guidewire a reason to avoid forcing bundled sales. Regulatory clearance and the added debt are the other variables to watch before the January 2027 closing window.
Outlook
Guidewire is making its largest bet since Cyence on the premise that AI-driven underwriting will become a core insurer system rather than a point solution. The $1.7B base price, the $400M earnout and the $1B loan all depend on that premise holding. The December earnings call should show how much revenue Hyperexponential brings and how Guidewire plans to fold it in.
